Alkermes Announces FDA Approval of VIVITROL® for Prevention of Relapse to Opioid Dependence

Published October 13, 2010

Alkermes Announces FDA Approval of VIVITROL® for Prevention of Relapse to Opioid Dependence
WALTHAM, Mass.–(BUSINESS WIRE)–Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL® for the prevention of relapse to opioid dependence, following opioid detoxification.
Read more on Business Wire

Man charged with DUI after faking drug overdose
PHOENIXVILLE — An Oreland man was arrested Saturday night on DUI charges, then he told police he allegedly took 30 pills to overdose, only to state that he did that to avoid arrest.
Read more on The Mercury